About Lacidipine API
Therapeutic Category Cardiovascular
CAS Number
103890-78-4
API Technology
Synthetic
Dose Form
Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
EUDMF
Mechanism of Action
Calcium channel blocker
Indication
Indicated for the treatment of hypertension either alone or in combination with other antihypertensive agents, including β-adrenoceptor antagonists, diuretics, and ACE-inhibitors
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
Dabigatran Etexilate Mesylate
Cardiovascular
Doxazosin Mesylate
Cardiovascular
Ezetimibe
Cardiovascular
Fondaparinux Sodium
Cardiovascular
Lacidipine
Cardiovascular
Tafamidis Free Acid
Cardiovascular
Metoprolol Succinate
Cardiovascular
Losartan Potassium
Cardiovascular
Atorvastatin Calcium (Form 1)
Cardiovascular
Acoramidis
Cardiovascular
Enalapril Maleate
Cardiovascular
Edoxaban
Cardiovascular
Amlodipine Besylate
Cardiovascular
Apixaban
Cardiovascular
Atorvastatin Calcium (Amorphous & Form 1)
Cardiovascular
Valsartan
Cardiovascular
Treprostinil
Cardiovascular
Ticagrelor
Cardiovascular
Bempedoic Acid
Cardiovascular
Sacubitril-Valsartan
Cardiovascular
Rivaroxaban
Cardiovascular
Ramipril
Cardiovascular
Clopidogrel Bisulfate (Form 1)
Cardiovascular
Clopidogrel Bisulfate (Form 2)
Cardiovascular